Novo Nordisk A/S

General ticker "NONOF" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $310.9B (TTM average)

Novo Nordisk A/S does not follow the US Stock Market performance with the rate: -19.7%.

Estimated limits based on current volatility of 2.9%: low 36.16$, high 38.76$

Factors to consider:

  • Company pays dividends (semi-annually): last record date 2025-08-18, amount 0.59$ (Y3.07%)
  • Total employees count: 3000 as of 2002
  • Current price 52.7% below estimated low
  • Earnings for 12 months up through Q4 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [78.77$, 122.72$]
  • 2025-12-31 to 2026-12-31 estimated range: [81.12$, 124.85$]

Financial Metrics affecting the NONOF estimates:

  • Negative: with PPE of 28.3 at the end of fiscal year the price was high
  • Positive: Operating profit margin, % of 44.19 > 18.38
  • Positive: 19.40 < Shareholder equity ratio, % of 30.80 <= 42.68
  • Positive: Inventory ratio change, % of 0.29 <= 0.80
  • Negative: Operating cash flow per share per price, % of 4.10 <= 6.64
  • Positive: Industry operating profit margin (median), % of 21.15 > 9.59
  • Positive: Return on assets ratio (scaled to [-100,100]) of 17.82 > 6.11
  • Positive: -4.43 < Investing cash flow per share per price, % of -4.37
  • Positive: Industry earnings per price (median), % of 5.35 > 4.49
  • Negative: 0.01 < Interest expense per share per price, % of 0.06

Similar symbols

Short-term NONOF quotes

Long-term NONOF plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue DKK176,954.00MM DKK232,261.00MM DKK290,403.00MM
Operating Expenses DKK102,145.00MM DKK129,687.00MM DKK162,064.00MM
Operating Income DKK74,809.00MM DKK102,574.00MM DKK128,339.00MM
Non-Operating Income DKK-5,747.00MM DKK2,100.00MM DKK-1,148.00MM
Interest Expense DKK378.00MM DKK542.00MM DKK1,640.00MM
R&D Expense DKK24,047.00MM DKK32,443.00MM DKK48,062.00MM
Income(Loss) DKK69,062.00MM DKK104,674.00MM DKK127,191.00MM
Taxes DKK13,537.00MM DKK20,991.00MM DKK26,203.00MM
Profit(Loss)* DKK55,525.00MM DKK83,683.00MM DKK100,988.00MM
Stockholders Equity DKK83,486.00MM DKK106,561.00MM DKK143,486.00MM
Inventory DKK24,388.00MM DKK31,811.00MM DKK40,849.00MM
Assets DKK241,257.00MM DKK314,486.00MM DKK465,795.00MM
Operating Cash Flow DKK78,887.00MM DKK108,908.00MM DKK120,968.00MM
Capital expenditure DKK14,753.00MM DKK38,896.00MM DKK51,309.00MM
Investing Cash Flow DKK-24,918.00MM DKK-43,892.00MM DKK-128,895.00MM
Financing Cash Flow DKK-51,797.00MM DKK-63,158.00MM DKK8,735.00MM
Earnings Per Share** DKK12.26 DKK18.67 DKK22.67
Ordinary share to ADR 1.00x 1.00x 1.00x

* Profit(Loss) attributable to entity.
** EPS are valid for ticker NVO. EPS are Split Adjusted, recent splits may be reflected with a delay.